hVIVO plc (AIM:HVO)
8.90
+0.05 (0.56%)
At close: Feb 12, 2026
hVIVO Revenue
hVIVO had revenue of 25.45M GBP in the half year ending June 30, 2025, a decrease of -11.18%. This brings the company's revenue in the last twelve months to 54.47M, down -18.96% year-over-year. In the year 2024, hVIVO had annual revenue of 66.22M with 12.87% growth.
Revenue (ttm)
54.47M
Revenue Growth
-18.96%
P/S Ratio
1.11
Revenue / Employee
180.96K
Employees
301
Market Cap
60.21M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 66.22M | 7.55M | 12.87% |
| Dec 31, 2023 | 58.67M | 7.97M | 15.72% |
| Dec 31, 2022 | 50.70M | 11.69M | 29.98% |
| Dec 31, 2021 | 39.01M | 17.06M | 77.76% |
| Dec 31, 2020 | 21.94M | 18.57M | 550.71% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Bioventix | 13.12M |
| Arecor Therapeutics | 5.06M |
| SkinBioTherapeutics | 4.64M |
| 4basebio | 1.78M |
| Fusion Antibodies | 1.60M |
| Aptamer Group | 1.20M |
| Ondine Biomedical | 1.18M |
| ImmuPharma | -69.96K |
hVIVO News
- 11 days ago - hVIVO plc (OPORF) Q4 2025 Sales/Trading Call Transcript - Seeking Alpha
- 13 days ago - hVIVO plc (OPORF) 2025 Sales/ Trading Statement Call - Slideshow - Seeking Alpha
- 3 months ago - Full Year 2024 hVIVO PLC Investor Presentation Transcript - GuruFocus
- 5 months ago - Half Year 2025 hVIVO PLC Earnings Presentation Transcript - GuruFocus
- 5 months ago - hVIVO plc 2025 Q2 - Results - Earnings Call Presentation - Seeking Alpha
- 11 months ago - Cathal Friel to step down as HVivo chairman - Independent Ireland
- 1 year ago - Half Year 2024 hVIVO PLC Investor Presentation Transcript - GuruFocus
- 1 year ago - Earnings rise 68pc at pharmaceutical services firm Hvivo - Independent Ireland